Exercise Oncology Service
Our research group studies the utility of different methods to characterize the chronic and long-term adverse cardiovascular side effects of conventional and novel cancer therapies. By investigating the use of these tools, we can better understand how cancer therapeutics damage organs such as the heart and skeletal muscles, as well as identify those individuals at high risk of cardiovascular side effects. In doing so, we can design therapeutic interventions to prevent and/or mitigate these devastating side effects.
Lee Jones, PhD
Research Focus
Exercise scientist Lee Jones focuses on the efficacy and mechanisms of exercise training on cardiovascular toxicities and tumor initiation and progression.Lab Members
Clinical Research Coordinator
Exercise Physiologist
Exercise Physiologist
Clinical Research Manager
Clinical Research Coordinator
Clinical Research Coordinator
Research Technician
Clinical Research Specialist
Exercise Physiologist
Clinical Research Supervisor
Exercise Physiologist
Patient Coordinator
Exercise Physiologist Supervisor
Exercise Physiologist Telemedicine Specialist
Research Regulatory Associate
Research Technician
Exercise Physiologist
Principal Investigator
Research Technician
Exercise Physiologist
Echocardiographer
Project Coordinator
Principal Investigator
- Jones LW, Habel LA, Weltzien E, Castillo A, Gupta D, Kroenke CH, Kwan ML, Queensberry CP, Scott J, Sternfeld B, Yu, A, Kushi LH, Caan BJ. Exercise and prognosis on the basis of clinicopathologic and molecular features in early stage breast cancer: The LACE and Pathways studies. Cancer Res. 2016 Aug 3.
- Scott JM, Nan L, Qi L, et al. Association of Exercise With Mortality in Adult Survivors of Childhood Cancer. JAMA Oncol. June 2018.
